377 related articles for article (PubMed ID: 33934394)
41. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
[TBL] [Abstract][Full Text] [Related]
42. Shelterin and the replisome: at the intersection of telomere repair and replication.
Cicconi A; Chang S
Curr Opin Genet Dev; 2020 Feb; 60():77-84. PubMed ID: 32171974
[TBL] [Abstract][Full Text] [Related]
43. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.
Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y
Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062
[TBL] [Abstract][Full Text] [Related]
44. Cancer chromosomes going to POT1.
Chang S
Nat Genet; 2013 May; 45(5):473-5. PubMed ID: 23619786
[TBL] [Abstract][Full Text] [Related]
45. RPA and POT1: friends or foes at telomeres?
Flynn RL; Chang S; Zou L
Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
[TBL] [Abstract][Full Text] [Related]
46. PTOP interacts with POT1 and regulates its localization to telomeres.
Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
[TBL] [Abstract][Full Text] [Related]
47. Pot1 and telomere maintenance.
Baumann P; Price C
FEBS Lett; 2010 Sep; 584(17):3779-84. PubMed ID: 20493859
[TBL] [Abstract][Full Text] [Related]
48. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
49. [Maintenance and expansion of hematopoietic stem cell by POT1].
Arai F
Rinsho Ketsueki; 2020; 61(9):1064-1070. PubMed ID: 33162500
[TBL] [Abstract][Full Text] [Related]
50. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer.
Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H
Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352
[TBL] [Abstract][Full Text] [Related]
51. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
52. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
53. The evolution of metazoan shelterin.
Myler LR; Kinzig CG; Sasi NK; Zakusilo G; Cai SW; de Lange T
Genes Dev; 2021 Dec; 35(23-24):1625-1641. PubMed ID: 34764137
[TBL] [Abstract][Full Text] [Related]
54. POT1 loss-of-function variants predispose to familial melanoma.
Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
[TBL] [Abstract][Full Text] [Related]
55. CGGBP1 phosphorylation constitutes a telomere-protection signal.
Singh U; Maturi V; Jones RE; Paulsson Y; Baird DM; Westermark B
Cell Cycle; 2014; 13(1):96-105. PubMed ID: 24196442
[TBL] [Abstract][Full Text] [Related]
56. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.
Miyoshi T; Kanoh J; Saito M; Ishikawa F
Science; 2008 Jun; 320(5881):1341-4. PubMed ID: 18535244
[TBL] [Abstract][Full Text] [Related]
57. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.
Motevalli A; Yasaei H; Virmouni SA; Slijepcevic P; Roberts T
Breast Cancer Res Treat; 2014 Jun; 145(3):581-91. PubMed ID: 24807106
[TBL] [Abstract][Full Text] [Related]
58. Investigation of deleterious effects of nsSNPs in the POT1 gene: a structural genomics-based approach to understand the mechanism of cancer development.
Amir M; Kumar V; Mohammad T; Dohare R; Hussain A; Rehman MT; Alam P; Alajmi MF; Islam A; Ahmad F; Hassan MI
J Cell Biochem; 2019 Jun; 120(6):10281-10294. PubMed ID: 30556179
[TBL] [Abstract][Full Text] [Related]
59. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
[TBL] [Abstract][Full Text] [Related]
60. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
